Search results
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 9 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 9 hours agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 19 hours agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 15 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 9 hours agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 13 hours agoThe agreement will also provide Sanofi with a sole license to the vaccine for use in combination...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 15 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 12 hours agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 13 hours agoThe deal encompasses the commercialization of a combined COVID-19 and flu shot, marking a pivotal...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 16 hours agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...